Christopher Belder

Research Interests

Neurology & Neurosurgery Neuroscience, Behaviour and Brain Health Cognition

Mr Christopher Belder

School of Medicine

College of Health

Date Institution name Country Title
The University of Adelaide Australia Bachelor of Medicine, Bachelor of Surgery (MBBS)

Date Title Institution Country
Fellow of the Royal Australasian College of Physicians (FRACP) Royal Australasian College of Physicians Australia

Year Citation
2025 O'Connor, A., Ryan, N. S., Belder, C. R. S., Lynch, D. S., Lahiri, N., Houlden, H., . . . O'Dowd, S. (2025). Genetic testing in dementia. Practical Neurology, 25(2), 127-136.
DOI Scopus2 WoS2 Europe PMC2
2025 Belder, C. R. S., Boche, D., Nicoll, J. A. R., Jaunmuktane, Z., Zetterberg, H., Schott, J. M., . . . Fox, N. C. (2025). Amyloid-related iatrogenic atrophy of the brain: data transparency is an urgent safety priority – Authors' reply. The Lancet Neurology, 24(3), 190.
DOI Scopus1 Europe PMC1
2025 Rosa-Grilo, M., Chughtai, H. R., Thomas, D. L., Alexander, D. C., Beament, M., Belder, C. R. S., . . . Fox, N. C. (2025). Ultra-fast MRI for dementia diagnosis and treatment eligibility: A prospective study. Alzheimer S and Dementia, 21(6), 12 pages.
DOI Europe PMC1
2024 Belder, C. R. S., Marshall, C. R., Jiang, J., Mazzeo, S., Chokesuwattanaskul, A., Rohrer, J. D., . . . Warren, J. D. (2024). Primary progressive aphasia: six questions in search of an answer. Journal of Neurology, 271(2), 1028-1046.
DOI Scopus27 WoS24 Europe PMC21
2024 Arber, C., Belder, C. R. S., Tomczuk, F., Gabriele, R., Buhidma, Y., Farrell, C., . . . Wray, S. (2024). The presenilin 1 mutation P436S causes familial Alzheimer's disease with elevated Aβ43 and atypical clinical manifestations. Alzheimer's and Dementia, 20(7), 4717-4726.
DOI Scopus5 WoS5 Europe PMC7
2024 Belder, C. R. S., Boche, D., Nicoll, J. A. R., Jaunmuktane, Z., Zetterberg, H., Schott, J. M., . . . Fox, N. C. (2024). Brain volume change following anti-amyloid β immunotherapy for Alzheimer's disease: amyloid-removal-related pseudo-atrophy. Lancet Neurology, 23(10), 1025-1034.
DOI Scopus34 WoS35 Europe PMC35
2023 Belder, C. R. S., Schott, J. M., & Fox, N. C. (2023). Insight Preparing for disease-modifying therapies in Alzheimer's disease. Lancet Neurology, 22(9), 782-783.
DOI WoS49 Europe PMC48
2023 Belder, C. R. S., Chokesuwattanaskul, A., Marshall, C. R., Hardy, C. J. D., Rohrer, J. D., & Warren, J. D. (2023). The problematic syndrome of right temporal lobe atrophy: Unweaving the phenotypic rainbow. Frontiers in Neurology, 13, 1082828-1-1082828-6.
DOI Scopus17 WoS16 Europe PMC18

Year Citation
2024 Llorente-Saguer, I., Gabriele, R., Bradshaw, T., Leckey, C. A., Belder, C. R. S., Chávez-Gutiérrez, L., . . . Arber, C. (2024). Unbiased data-driven analysis of five amyloid-beta peptides for biomarker investigations in familial Alzheimer’s disease.
DOI

Connect With Me

External Profiles

Other Links